Evidence map›Paper›PMID 30059510›Full record

ArticlePloS one2018

Comparison of the sympathetic stimulatory abilities of B-type procyanidins based on induction of uncoupling protein-1 in brown adipose tissue (BAT) and increased plasma catecholamine (CA) in mice.

Yuta Nakagawa, Kana Ishimura, Satomi Oya, Masaki Kamino, Yasuyuki Fujii, Fumio Nanba, Toshiya Toda, Takeshi Ishii, Takahiro Adachi, Yoshitomo Suhara and 1 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Flavonoids, gut microbiota, and host lipid metabolism.Engineering in life sciences · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Adipocyte-Specific Inhibition ofFrontiers in endocrinology · 2021
    Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Yuta NakagawaDepartment of Bio-science and Engineering, Shibaura Institute of Technology, Munumaku, Saitama, Japan.
Kana IshimuraDepartment of Bio-science and Engineering, Shibaura Institute of Technology, Munumaku, Saitama, Japan.
Satomi OyaDepartment of Bio-science and Engineering, Shibaura Institute of Technology, Munumaku, Saitama, Japan.
Masaki KaminoDepartment of Bio-science and Engineering, Shibaura Institute of Technology, Munumaku, Saitama, Japan.
Yasuyuki FujiiDepartment of Bio-science and Engineering, Shibaura Institute of Technology, Munumaku, Saitama, Japan.
Fumio NanbaDepartment of Research and Development, Fujicco. Co. Ltd., Kobe, Hyogo, Japan.
Toshiya TodaDepartment of Research and Development, Fujicco. Co. Ltd., Kobe, Hyogo, Japan.
Takeshi IshiiDepartment of Nutrition, Kobe Gakuin University, Kobe, Japan.
Takahiro AdachiDepartment of Immunology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.
Yoshitomo SuharaDepartment of Bio-science and Engineering, Shibaura Institute of Technology, Munumaku, Saitama, Japan.
Naomi OsakabeDepartment of Bio-science and Engineering, Shibaura Institute of Technology, Munumaku, Saitama, Japan.ORCID 0000-0001-8159-7053
Shibaura Institute of Technology · JPKobe Gakuin University · JPTokyo Medical and Dental University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWe previously found that elevated energy expenditure following a single oral dose of flavan 3-ols (FL), a mixture of catechins and B type procyanidins, is caused by sympathetic nerve activation. In the present study, we compared the activity of the FL components (-)-epicatechin (EC; monomer), procyanidin B2 (B2; dimer), procyanidin C1 (C1; trimer), cinnamtannin A2 (A2; tetramer), and more than pentamer fraction (P5).

methodsMale ICR mice were treated with a single oral dose of FL, EC, B2, C1, A2, or P5. The animals were sacrificed and blood and brown adipose tissue (BAT) sampled. The plasma catecholamine (CA) levels and BAT uncoupling protein (UCP)-1 mRNA expression were determined.

resultsA single dose of 10 mg/kg FL significantly increased plasma CA and UCP-1 mRNA levels. B2, C1, and A2, but not EC and P5 (all at 1 mg/kg), significantly increased plasma adrenaline levels. Plasma noradrenaline was significantly elevated by B2 and A2, but not by EC, C1, or P5. UCP-1 mRNA levels were significantly increased by C1 and P5. In the dose response study of A2, 10-3 mg/kg A2 increased UCP-1 mRNA levels significantly, but not 10-2 and 10-1 mg/kg A2. In addition, combination treatment with 10-1 mg/kg A2 and yohimbine, an α2 adrenalin blocker, remarkably increased UCP-1 mRNA levels.

conclusionThese results suggest that FL and its components, except EC, increase UCP-1 mRNA and plasma CA with varying efficacy.

Indexed as

Adipose Tissue, BrownAdministration, OralAnimalsCatecholaminesGene Expression RegulationGlycine maxMaleMice, Inbred ICRProanthocyanidinsRNA, MessengerSeedsUncoupling Protein 1CatecholaminesProanthocyanidinsRNA, MessengerUcp1 protein, mouseUncoupling Protein 1

Identifiers

PMID30059510
PMCPMC6066223
OpenAlexW2883879531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.